Why Diagnostics Alone Don't Make a Longevity Business
Founder & Managing Partner
Kamal Hassan is the Founder & Managing Partner of TURN8 — the venture operating partner for GCC corporates and sovereign-linked institutions. With 30+ years of experience across the United States, MENA, and Europe, Kamal has built a rare track record at the intersection of corporate innovation, venture capital, and operational execution.
Anyone building a diagnostics-led longevity clinic business model needs to answer this question before buying the device, not after.
Every beauty house is adding a diagnostic right now. Lancôme puts one in stores. Estée Lauder has one in a resort spa in Costa Rica. But a diagnostic device and a genuine longevity business are not the same thing.
The Asset vs. the Device
The Estée Lauder Companies Inc. built its age-assessment model on 2,800 women across six decades. Any competitor can buy the same skin-analysis device next month – but only one of those two things is actually a business.
The Data Asset Behind the Brand
In April, Estée Lauder announced a 12-week trial on its Re-Nutriv line, along with a model showing how perceived age changes across six decades, built on that same 2,800-woman group. That data asset, not the device itself, is what sits behind the brand.
A Result That Just Sits There
A diagnostic result showing low collagen or high stress hormones just sits there as information until someone actually does something with it. The device generates a number. It does not generate a business on its own.
When a Marketing Claim Isn't Clinical Evidence
Look closely at the claim marketed hardest around these diagnostics, such as “plus 33% NAD.” Read the small print: tested in a lab, on an ingredient, for 24 hours. It sells the product well. It is marketing dressed up as science, not evidence about what happens to an actual customer.
The Mistake Teams Make Every Time
Teams buy the diagnostic first because it is the part you can photograph and put in a deck. Nothing gets built for what happens after someone actually receives their result.
The Question That Actually Tells You If There's a Business
The test itself is not the useful signal. The useful question is what the second check is scheduled for, and who is responsible for the plan in between. No second check means there is no business here – just a product with a test attached.
What This Means for a Beauty or Wellness Longevity Brand
For anyone building a beauty longevity brand, the real question is what happens to a customer’s test result after it lands in their inbox. That follow-up structure is the entire business, not the diagnostic that generated the number.
Frequently Asked Questions
Why isn't a skin-analysis or diagnostic device a longevity business on its own?
Because any competitor can buy the same device. The actual asset is the data and follow-up model built on top of it – for example a 2,800-person panel tracked across six decades – not the device itself, which is generic and easily copied.
What's the difference between a marketing claim and clinical evidence in beauty diagnostics?
A claim like “plus 33% NAD” tested in a lab, on an ingredient, for 24 hours, is marketing dressed up as science – it says nothing about outcomes for an actual customer using the finished product over time.
What mistake do most teams make when building a diagnostic-led longevity or beauty brand?
They buy the diagnostic first because it photographs well and fits neatly in a pitch deck, then build nothing for what happens after a customer actually receives their result.
What question actually reveals whether a diagnostic-led venture is a real business?
What the second check is scheduled for, and who is responsible for the plan in between. No second check means there is no business – just a product with a test attached.
What should a beauty or wellness longevity brand focus on beyond the diagnostic itself?
What happens to a customer’s test result after it lands in their inbox – the follow-up structure and ongoing plan is the actual business, not the diagnostic that produced the initial number.